NO984920D0 - Sammensetninger omfattende en nitroneforbindelse for anvendelse ved behandling av okulµr inflammasjon - Google Patents
Sammensetninger omfattende en nitroneforbindelse for anvendelse ved behandling av okulµr inflammasjonInfo
- Publication number
- NO984920D0 NO984920D0 NO984920A NO984920A NO984920D0 NO 984920 D0 NO984920 D0 NO 984920D0 NO 984920 A NO984920 A NO 984920A NO 984920 A NO984920 A NO 984920A NO 984920 D0 NO984920 D0 NO 984920D0
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- treatment
- ocular inflammation
- nitron compound
- compound
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title abstract 3
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- -1 nitron compound Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 206010046851 Uveitis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1627696P | 1996-04-23 | 1996-04-23 | |
PCT/US1997/006604 WO1997039751A1 (en) | 1996-04-23 | 1997-04-23 | Compositions comprising a nitrone compound for use in treating ocular inflammation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984920D0 true NO984920D0 (no) | 1998-10-22 |
NO984920L NO984920L (no) | 1998-12-23 |
Family
ID=21776304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984920A NO984920L (no) | 1996-04-23 | 1998-10-22 | Preparater omfattende en nitronforbindelse for anvendelse ved behandling av okulµr inflammasjon |
Country Status (13)
Country | Link |
---|---|
US (2) | US5972977A (no) |
EP (1) | EP0910370B1 (no) |
JP (1) | JP2000509375A (no) |
CN (1) | CN1219130A (no) |
AT (1) | ATE263559T1 (no) |
AU (1) | AU721531B2 (no) |
CA (1) | CA2252494A1 (no) |
DE (1) | DE69728536T2 (no) |
IL (1) | IL126725A0 (no) |
NO (1) | NO984920L (no) |
NZ (1) | NZ332561A (no) |
TW (1) | TW450952B (no) |
WO (1) | WO1997039751A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050107366A1 (en) * | 1991-06-18 | 2005-05-19 | Carney John M. | Spin trapping pharmaceutical compositions and methods for use thereof |
CA2323490A1 (en) * | 1998-03-13 | 1999-09-16 | Lowell D. Waterbury | Inhibition of angiogenesis |
ATE271384T1 (de) * | 1998-05-19 | 2004-08-15 | Renovis Inc | Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen |
US6083989A (en) | 1999-05-18 | 2000-07-04 | Centaur Pharmaceuticals, Inc. | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
EP1079820A1 (en) | 1998-05-19 | 2001-03-07 | Centaur Pharmaceuticals, Inc. | Benzamide therapeutics for the treatment of inflammatory bowel disease |
AU750599B2 (en) * | 1998-07-17 | 2002-07-25 | Renovis, Inc. | Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
US6730700B2 (en) | 1998-12-02 | 2004-05-04 | Renovis, Inc. | 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
UA66401C2 (en) * | 1998-12-02 | 2004-05-17 | Sentor Pharmaceuticals Inc | 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same |
WO2000074672A1 (en) * | 1999-06-09 | 2000-12-14 | Department Of The Army, U.S. Government | Method and compositions for treating and preventing retinal damage |
US20050059638A1 (en) * | 2003-08-04 | 2005-03-17 | Kelly Michael G. | Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
US20050182060A1 (en) * | 2004-02-13 | 2005-08-18 | Kelly Michael G. | 2-Substituted and 4-substituted aryl nitrone compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4153722A (en) * | 1977-10-06 | 1979-05-08 | William H. Rorer, Inc. | Method of treatment |
US5036097A (en) * | 1989-10-17 | 1991-07-30 | Oklahoma Medical Research Foundation | Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration |
CA2069961C (en) * | 1989-10-17 | 2000-05-02 | John M. Carney | Method and compositions for inhibition of disorders associated with oxidative damage |
US5025032A (en) * | 1989-10-17 | 1991-06-18 | Oklahoma Medical Research Foundation | Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage |
EP0590072B1 (en) * | 1991-06-18 | 2001-12-05 | Oklahoma Medical Research Foundation | Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins |
US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
-
1997
- 1997-04-23 CN CN97194855A patent/CN1219130A/zh active Pending
- 1997-04-23 US US08/847,386 patent/US5972977A/en not_active Expired - Fee Related
- 1997-04-23 TW TW086105289A patent/TW450952B/zh not_active IP Right Cessation
- 1997-04-23 WO PCT/US1997/006604 patent/WO1997039751A1/en active IP Right Grant
- 1997-04-23 IL IL12672597A patent/IL126725A0/xx unknown
- 1997-04-23 AU AU27366/97A patent/AU721531B2/en not_active Ceased
- 1997-04-23 DE DE69728536T patent/DE69728536T2/de not_active Expired - Fee Related
- 1997-04-23 NZ NZ332561A patent/NZ332561A/en unknown
- 1997-04-23 EP EP97921289A patent/EP0910370B1/en not_active Expired - Lifetime
- 1997-04-23 JP JP9538232A patent/JP2000509375A/ja not_active Ceased
- 1997-04-23 CA CA002252494A patent/CA2252494A1/en not_active Abandoned
- 1997-04-23 AT AT97921289T patent/ATE263559T1/de not_active IP Right Cessation
-
1998
- 1998-10-22 NO NO984920A patent/NO984920L/no not_active Application Discontinuation
-
1999
- 1999-09-20 US US09/399,733 patent/US6140356A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2736697A (en) | 1997-11-12 |
DE69728536D1 (de) | 2004-05-13 |
US6140356A (en) | 2000-10-31 |
EP0910370B1 (en) | 2004-04-07 |
DE69728536T2 (de) | 2005-02-24 |
US5972977A (en) | 1999-10-26 |
NO984920L (no) | 1998-12-23 |
NZ332561A (en) | 2001-01-26 |
CN1219130A (zh) | 1999-06-09 |
JP2000509375A (ja) | 2000-07-25 |
ATE263559T1 (de) | 2004-04-15 |
AU721531B2 (en) | 2000-07-06 |
IL126725A0 (en) | 1999-08-17 |
EP0910370A1 (en) | 1999-04-28 |
WO1997039751A1 (en) | 1997-10-30 |
TW450952B (en) | 2001-08-21 |
CA2252494A1 (en) | 1997-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO973516L (no) | Behandling av urininkontinens ved anvendelse av (S)-oksybutynin og (S)-desetyloksybutynin | |
CA2264901A1 (fr) | Association inhibiteurs de no synthase et piegeurs des formes reactives de l'oxygene | |
WO1999013862A3 (en) | A pharmaceutical composition for treating dysmenorrhea and premature labor | |
CA2245142A1 (en) | New phenanthridines | |
CA2223514A1 (en) | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith | |
MX9702380A (es) | Nuevas carboxamidas con actividad antifungica. | |
DE69429524T2 (de) | Aminocyclohexylester und ihre anwendung | |
MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
NO984920D0 (no) | Sammensetninger omfattende en nitroneforbindelse for anvendelse ved behandling av okulµr inflammasjon | |
MX9710252A (es) | Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento. | |
WO2000018316A3 (en) | Sustained release, and comfortable ophthalmic composition and method for ocular therapy | |
MY106109A (en) | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions | |
AU2162700A (en) | Supramolecular complexes containing therapeutic agents | |
CA2198580A1 (en) | Combination therapy to treat osteoporosis | |
DE60040616D1 (de) | Verfahren zur behandlung maligner zellen eines patienten und pharmazeutische zusammensetzung zu dessen anwendung | |
IL141515A0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
US5798392C1 (en) | Sulfonyl fluorides for the treatment of alzheimer's disease | |
GEP20032975B (en) | Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition | |
ES2190581T3 (es) | 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico. | |
MX9701606A (es) | Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno. | |
WO1996021670A3 (en) | Antifungal fusacandins | |
MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
MX9701532A (es) | Procedimiento para aumentar los niveles de testosterona. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |